Robert J. Schneider

Biography

 Dr. Schneider leads the Office of Therapeutics Alliances (OTA), guiding the activities of both the Translational Science Incubator and Virtual Accelerator programs, overseeing all aspects, from academic discovery to industry, nonprofit, foundation and federal grant partnerships. As director, Dr. Schneider participates in development of new drug discovery partnerships, licensing, project management activities, evaluation of relevant NYU patent portfolios, development of therapeutics-focused translational research working groups, and implementation of contract research organization opportunities.  Dr. Schneider holds the Albert B. Sabin endowed chair for molecular pathogenesis at NYU School of Medicine. His laboratory research and participation in therapeutic clinical trials are directed to the development, progression and metastasis of breast and other cancers, and the interplay of the inflammatory response. He has published over 140 research papers in these and related areas. Dr. Schneider is also an associate director of the NYU Perlmutter Cancer Center, director of Translational Cancer Research, and co-leader of the Breast Cancer Research Program at NYU School of Medicine. He is the recipient of a number of research awards, holds a number of patents, and is a founding scientist of five biotechnology/small pharmaceutical companies.  

Research Interest

 Biotechnology, Instrumentation Technology